REPORT ID 7089

Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2022

Publish Date
2-Nov-17
Pages
99
Format
Electronic (PDF)

This report studies the global Non-invasive Cancer Diagnosis market, analyzes and researches the Non-invasive Cancer Diagnosis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Gen-Probe Inc.
    A&G Pharmaceutical
    Affymetrix Inc.
    Digene Corporation
    Quest Diagnostics Inc.
    BioView Inc.
    LabCorp
    AVIVA Biosciences Corporation
    Precision Therapeutics

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Clinical Chemistry
    Immunochemistry/Immunoassay
    Molecular Diagnostics
    Others

Market segment by Application, Non-invasive Cancer Diagnosis can be split into
    Blood Cancer
    Solid Tumors
    Breast Cancer
    Lung Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2022
1 Industry Overview of Non-invasive Cancer Diagnosis
    1.1  Non-invasive Cancer Diagnosis Market Overview
        1.1.1 Non-invasive Cancer Diagnosis Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Non-invasive Cancer Diagnosis Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Non-invasive Cancer Diagnosis Market by Type
        1.3.1 Clinical Chemistry
        1.3.2 Immunochemistry/Immunoassay
        1.3.3 Molecular Diagnostics
        1.3.4 Others
    1.4 Non-invasive Cancer Diagnosis Market by End Users/Application
        1.4.1 Blood Cancer
        1.4.2 Solid Tumors
        1.4.3 Breast Cancer
        1.4.4 Lung Cancer
        1.4.5 Others

2 Global Non-invasive Cancer Diagnosis Competition Analysis by Players
    2.1 Non-invasive Cancer Diagnosis Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Gen-Probe Inc.
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 A&G Pharmaceutical
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Affymetrix Inc.
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Digene Corporation
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Quest Diagnostics Inc.
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 BioView Inc.
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 LabCorp
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 AVIVA Biosciences Corporation
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Precision Therapeutics
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Non-invasive Cancer Diagnosis Revenue (Value) (2012-2017)
        3.9.5 Recent Developments

4 Global Non-invasive Cancer Diagnosis Market Size by Type and Application (2012-2017)
    4.1 Global Non-invasive Cancer Diagnosis Market Size by Type (2012-2017)
    4.2 Global Non-invasive Cancer Diagnosis Market Size by Application (2012-2017)
    4.3 Potential Application of Non-invasive Cancer Diagnosis in Future
    4.4 Top Consumer/End Users of Non-invasive Cancer Diagnosis

5 United States Non-invasive Cancer Diagnosis Development Status and Outlook
    5.1 United States Non-invasive Cancer Diagnosis Market Size (2012-2017)
    5.2 United States Non-invasive Cancer Diagnosis Market Size and Market Share by Players (2016 and 2017)

6 EU Non-invasive Cancer Diagnosis Development Status and Outlook
    6.1 EU Non-invasive Cancer Diagnosis Market Size (2012-2017)
    6.2 EU Non-invasive Cancer Diagnosis Market Size and Market Share by Players (2016 and 2017)

7 Japan Non-invasive Cancer Diagnosis Development Status and Outlook
    7.1 Japan Non-invasive Cancer Diagnosis Market Size (2012-2017)
    7.2 Japan Non-invasive Cancer Diagnosis Market Size and Market Share by Players (2016 and 2017)

8 China Non-invasive Cancer Diagnosis Development Status and Outlook
    8.1 China Non-invasive Cancer Diagnosis Market Size (2012-2017)
    8.2 China Non-invasive Cancer Diagnosis Market Size and Market Share by Players (2016 and 2017)

9 India Non-invasive Cancer Diagnosis Development Status and Outlook
    9.1 India Non-invasive Cancer Diagnosis Market Size (2012-2017)
    9.2 India Non-invasive Cancer Diagnosis Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Non-invasive Cancer Diagnosis Development Status and Outlook
    10.1 Southeast Asia Non-invasive Cancer Diagnosis Market Size (2012-2017)
    10.2 Southeast Asia Non-invasive Cancer Diagnosis Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Non-invasive Cancer Diagnosis Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Non-invasive Cancer Diagnosis Revenue and Growth Rate (2017-2022)
        11.1.2 EU Non-invasive Cancer Diagnosis Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Non-invasive Cancer Diagnosis Revenue and Growth Rate (2017-2022)
        11.1.4 China Non-invasive Cancer Diagnosis Revenue and Growth Rate (2017-2022)
        11.1.5 India Non-invasive Cancer Diagnosis Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Non-invasive Cancer Diagnosis Revenue and Growth Rate (2017-2022)
    11.2 Global Non-invasive Cancer Diagnosis Market Size (Value) by Type (2017-2022)
    11.3 Global Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)

12 Non-invasive Cancer Diagnosis Market Dynamics
    12.1 Non-invasive Cancer Diagnosis Market Opportunities
    12.2 Non-invasive Cancer Diagnosis Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Non-invasive Cancer Diagnosis Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Non-invasive Cancer Diagnosis Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source